Marijuana users no more likely to experience depression, psychosis or asthma … – The Independent


The Independent

Marijuana users no more likely to experience depression, psychosis or asthma
The Independent
Even though 22% of the participants were chronic users of marijuana – smoking the drug regularly every week – they were no more likely than their old schoolmates to experience depression, anxiety, psychosis or asthma by their mid-30s, said the report.
Marijuana Smoking Among Teens Not Linked To Future Asthma, Depression: StudyYibada (English Edition)
Use of marijuana not linked to asthma, depression and lung cancerNYC Today
Teen Marijuana Use Not Linked to Depression, Asthma, Anxiety, High Blood Echo Examiner
Northern Californian –Jewish Business News –NewsQuench
all 110 news articles »

View full post on asthma – Google News

Indians highest users of asthma medicines yet quality of life low: survey – Indian Express

Indians highest users of asthma medicines yet quality of life low: survey
Indian Express
Though the use of medicines to treat asthma is the highest in india, the country also reported the lowest levels of controlled asthmatics. India has the highest levels of overnight hospitalisations. Majority of the respondents said they had to leave

View full post on asthma – Google News

Asthma treatment users a little bit shorter – Regina Leader-Post


HealthNewsDigest.com

Asthma treatment users a little bit shorter
Regina Leader-Post
Results of a long-term asthma study found that children who used an inhaled steroid before they entered puberty were about a 1.27 cm shorter as adults than those who did not. Doctors have known since the 1990s that inhaled steroids taken for asthma can
'Chaotic' family life damages asthma adherenceGP online
Children Treated With Inhaled Steroids Are Shorter Than Peers, According To Doctor Tipster

all 4 news articles »

View full post on asthma – Google News

Protexo asthma device creates filtered air zone over users’ beds – The Verge


Medgadget.com

Protexo asthma device creates filtered air zone over users' beds
The Verge
The Airsonett Protexo is a futuristic-looking device that's designed to help atopic (allergen-triggered) asthma sufferers while they sleep — a claim that's been bolstered by a recent study in a
Now treat asthma without drugsHindustan Times
Protexo Device Eases the Wheeze of Asthma SufferersMedgadget.com
Reduction of Asthma Attacks Binds to Laminar Air Flow DeviceHeal Blog (blog)
Geeky gadgets
all 7 news articles »

View full post on asthma – Google News

FDA to Primatene Users: Get Asthma Prescription Now – WebMD


ThirdAge

FDA to Primatene Users: Get Asthma Prescription Now
WebMD
31, and prescription inhalers are the only alternative to the over-the-counter asthma drug. Don't wait to get that prescription. The FDA warns that Primatene supplies may not last until the end of the year. "All inhalers that might substitute require a
Asthma inhalers being phased out over environmental worriesCBS News
Asthma Inhaler Primatene Mist Going Off the MarketU.S. News & World Report
FDA phases out inhaler due to environmental impactUSA Today
ThirdAge –Reuters –msnbc.com
all 248 news articles »

View full post on asthma – Google News

Officials Consider Prescriptions to Keep Meds Away From Meth Users – Patch.com

Officials Consider Prescriptions to Keep Meds Away From Meth Users
Patch.com
Joy Krieger, executive director for the Asthma and Allergy Foundation of America, St. Louis Chapter, told council members that ephedrine or pseudoephedrine is the preferred medication to treat sinus or colds for those who have asthma.
Prescriptions to be required in Franklin County for pseudoephedrineSTLtoday.com

all 4 news articles »

View full post on asthma – Google News

HIV/AIDS Treatment Curbs Spread of HIV Among Drug Users, According to NIH Supported Study

Highly active antiretroviral therapy (HAART), currently known for its therapeutic benefits against HIV, also reduced the spread of the virus among people with a history of injection drug use, according to a population-based study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published today in the Lancet.

View full post on National Institutes of Health (NIH) News Releases